War on the Rocks: Biomanufacturing Could Address Pentagon Supply Chain Fragility
If the Abraham Lincoln's supply shortfalls during an extended high-tempo deployment become the canonical case study in congressional testimony, the pressure on the Pentagon to stand up a dedicated forward biomanufacturing program increases materially — and Biosphere and similarly positioned startups move from unsolicited proposals to a named program of record they can bid against.
The second-order effect is that a DoD program office, once stood up, would need to define feedstock standards and containment requirements for forward-deployed biological systems, a regulatory question that currently has no owner inside the Pentagon acquisition system.
INDOPACOM and CENTCOM logistics planners now have a published, credentialed argument — co-authored by a Carnegie fellow and a biomanufacturing entrepreneur — that the Abraham Lincoln deployment exposed a procurement gap the FYDP has not addressed.
The authors' call for a dedicated DoD program to develop and demonstrate deployable biomanufacturing systems gives congressional staffers and OSD(R&E) a concrete ask to attach to the FY28 budget cycle.
Because one author leads business development for Biosphere, a biomanufacturing infrastructure company, the policy recommendation and the commercial interest are not fully separable — readers should weight the strategic argument on its merits while noting that framing.
Has OSD(R&E) or DARPA already funded a deployable biomanufacturing demonstration program, or is the gap the authors describe genuinely unfilled in the current FYDP?
Fault Lines
Strategic intelligence, synthesized daily — with a public track record. Every call graded against what actually happened.